Latest Sensei robotic catheter system Stories
U.S. scientists say they've found catheter ablation is much more efficient than drugs in treating atrial fibrillation -- a type of abnormal heart rhythm. Research leader Dr.
AUSTIN, Texas, May 11 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St.
New Technology Used to Treat Abnormal Heart Rhythms AUSTIN, Texas, March 3 /PRNewswire/ -- On Tuesday, March 3, 2009, the Texas Cardiac Arrhythmia Institute at St.
St. Jude Medical, Inc. (NYSE:STJ) today announced it has received approval for European CE Marking of its SJM Confirm(TM) implantable cardiac monitor (ICM), a compact device designed to detect atrial fibrillation (AF) and other abnormal heart rhythms.
Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the TOCCATA (TOuCh+ for CATheter Ablation) clinical study to evaluate the safety of the TactiCath(TM) system with enrollment gaining momentum.
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the release of its new atrial fibrillation (AF) reporting package to enhance its current AF Management Program.
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that a team of physicians led by Professor Nick Cheshire at St.
CARLSBAD, Calif., Sept. 2 /PRNewswire/ -- Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were presented by Dr. Lucas Boersma of the St.